查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1661255

靜脈注射液市場規模、佔有率、趨勢及預測（按類型、營養成分及地區分類），2025 年至 2033 年

Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球靜脈注射溶液市場規模價值 156 億美元。北美目前佔據市場主導地位，到 2024 年的市場佔有率將超過 40.7%。

靜脈（IV）溶液是指用於將液體直接注射到患者血液中的無菌液體。它包括等滲透壓、高滲透壓和低滲透壓溶液，可滿足不同的醫療需求。它們由各種成分製成，例如水、電解質、糖、維生素和藥物。靜脈注射溶液廣泛用於水合療法、營養支持、藥物傳遞、輸血、化療、疼痛管理、矯正電解質失衡和排毒治療。它們具有多種益處，例如控制管理、減少對消化系統的影響、客製化營養輸送、直接血液進入和增強恢復支持。

醫院、診所和專科護理中心等醫療設施的快速擴張為靜脈注射治療創造了更多的機會，從而推動了市場的成長。此外，政府和監管機構實施的支持政策確保整個醫療機構能夠獲得高品質的靜脈注射溶液，這對市場成長產生了積極影響。此外，緊急情況和外科手術中對靜脈注射解決方案的需求不斷成長，也促進了市場的成長。除此之外，越來越多的人開始選擇家庭醫療保健，即患者在自己家中接受治療，這也推動了對專門靜脈注射解決方案的需求。除此之外，在流行病等全球衛生緊急情況下，用於快速治療大量患者的產品應用不斷增加，正在催化市場的成長。

靜脈注射解決方案市場趨勢/促進因素：

疾病盛行率不斷上升

糖尿病、心血管疾病、癌症和需要靜脈注射治療的急性病等慢性疾病的發生率不斷上升，是推動市場成長的重要因素。此外，生活方式的改變、環境因素和遺傳傾向等新興全球趨勢導致慢性病的增加，也成為另一個促進成長的因素。此外，一些慢性和急性疾病需要將液體、營養物質或藥物直接注入血液中。與此相符的是，靜脈注射溶液有助於精確輸送必需的營養素和藥物，並確保患者快速康復。此外，它們還能提供更快、更可控的護理，特別是在危急情況下。

老年人口不斷增加

老年人口的不斷增加對靜脈注射液市場的成長貢獻巨大。老齡人口對各種健康問題和慢性病的高度敏感性，通常需要複雜的醫療干預，包括靜脈注射治療，這推動了市場的成長。此外，免疫系統較弱、器官功能下降以及其他與年齡相關的生理變化使得老年人更容易感染和生病，從而促進了市場的成長。與此相符的是，靜脈注射溶液對於提供必需的水分、營養和藥物至關重要，以確保治療的針對性和有效性。此外，廣泛使用靜脈注射液來恢復電解質（如鈉、鉀、鈣和鎂）失衡，是另一個促進生長的因素。

快速的技術進步

醫療保健技術和靜脈注射液生產技術的進步促進了市場的成長。與此相符的是，新技術正在使得制定更專業的解決方案成為可能，滿足特定患者的需求，並提高靜脈注射治療的效率和安全性。此外，輸液幫浦和輸送系統的最新創新使醫療保健提供者能夠以更高的精度和控制力實施治療，這對市場成長產生了積極的影響。此外，監測和管理靜脈注射療法的技術突破，降低了併發症的風險並改善了患者的治療效果，也是另一個促進成長的因素。此外，大量的研發工作（R&D）致力於生物相容性、個人化治療方案以及整合人工智慧（AI）等技術以增強護理，從而支持市場的成長。

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球靜脈注射液市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場區隔：按類型
  • 市場區隔：依營養成分
  • 市場分佈：按地區
  • 市場預測
  • SWOT 分析
    • 概述
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • 價值鏈分析
    • 概述
    • 研究與開發
    • 原物料採購
    • 製造業
    • 行銷
    • 分配
    • 最終用途
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅

第6章：市場細分：依類型

  • 部分腸外營養
    • 市場趨勢
    • 市場預測
  • 完全腸外營養
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依營養成分

  • 碳水化合物
    • 市場趨勢
    • 市場預測
  • 鹽和電解質
    • 市場趨勢
    • 市場預測
  • 礦物質
    • 市場趨勢
    • 市場預測
  • 維生素
    • 市場趨勢
    • 市場預測
  • 胺基酸
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 市場趨勢
    • 市場預測
  • 歐洲
    • 市場趨勢
    • 市場預測
  • 亞太地區
    • 市場趨勢
    • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 市場預測
  • 拉丁美洲
    • 市場趨勢
    • 市場預測

第 9 章：靜脈注射液製造程序

  • 產品概述
  • 原料需求
  • 製造過程
  • 成功的關鍵因素和風險因素

第 10 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Ajinomoto
    • B. Braun Melsungen
    • Baxter International Inc.
    • Grifols
    • Otsuka Pharmaceutical
Product Code: SR112025A891

The global intravenous solutions market size was valued at USD 15.6 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 23.3 Billion by 2033, exhibiting a CAGR of 4.53% from 2025-2033. North America currently dominates the market, holding a market share of over 40.7% in 2024. The growth of the North American region is driven by advanced healthcare infrastructure, rising chronic disease prevalence, and increasing elderly population.

Intravenous (IV) solutions refer to sterile liquids used to administer fluids directly into a patient's bloodstream. It includes isotonic, hypertonic, and hypotonic solutions, catering to different medical needs. They are produced using various ingredients, such as water, electrolytes, sugars, vitamins, and medications. IV solutions are widely used in hydration therapy, nutritional support, medication delivery, blood transfusion, chemotherapy, pain management, correcting electrolyte imbalances, and detoxification treatments. They offer several benefits, such as controlled administration, reduced digestive system impact, tailored nutrient delivery, direct bloodstream access, and enhanced recovery support.

The rapid expansion of healthcare facilities, such as hospitals, clinics, and specialized care centers, which are generating more opportunities for IV treatments, is propelling the market growth. Additionally, the imposition of supportive policies by governments and regulatory bodies to ensure the availability of high-quality intravenous solutions across healthcare facilities is positively influencing the market growth. Furthermore, the growing demand for IV solutions in emergency scenarios and surgical procedures is contributing to the market growth. Apart from this, the increasing shift towards home healthcare, where patients receive treatment in their own homes, is facilitating the demand for specialized IV solutions. Besides this, the rising product application in treating a large number of patients quickly during global health emergencies, such as pandemics, is catalyzing the market growth.

Intravenous Solutions Market Trends/Drivers:

The increasing prevalence of disease

The heightened prevalence of chronic diseases, such as diabetes, cardiovascular ailments, cancer, and acute conditions, which necessitate IV treatments, is a prominent factor propelling the market growth. Furthermore, emerging global trends, such as lifestyle changes, environmental factors, and genetic predispositions, which lead to an increase in chronic conditions, are acting as another growth-inducing factor. Additionally, several chronic and acute illnesses require direct administration of fluids, nutrients, or medications into the bloodstream. In line with this, IV solutions facilitate precise delivery of essential nutrients and medication and ensure quick patient recovery. In addition, they also enable faster, more controlled care, particularly in critical situations.

The rising geriatric population

The rising geriatric population is contributing significantly to the growth of the IV solutions market. The high susceptibility of the aging population to various health issues and chronic conditions, which often require complex medical interventions, including IV therapy, is propelling the market growth. Furthermore, the presence of a weaker immune system, reduced organ functionality, and other age-related physiological changes that make geriatric individuals more prone to infections and diseases are facilitating the market growth. In line with this, IV solutions are vital in providing essential hydration, nutrients, and medications, ensuring that the treatments are targeted and efficient. Moreover, the widespread utilization of IV solutions to restore imbalance in electrolytes, such as sodium, potassium, calcium, and magnesium, is acting as another growth-inducing factor.

The rapid technological advancements

Technological advancements in medical care and the production of IV solutions are contributing to the market growth. In line with this, new technologies are enabling the formulation of more specialized solutions, catering to specific patient needs, and enhancing the efficiency and safety of IV therapies. Furthermore, the recent innovations in infusion pumps and delivery systems, which allow healthcare providers to administer treatments with greater precision and control, are positively influencing the market growth. Additionally, technological breakthroughs in monitoring and managing IV therapies to lower the risk of complications and improve patient outcomes are acting as another growth-inducing factor. Moreover, extensive research and development (R&D) efforts focusing on biocompatibility, personalized treatment plans, and integrating technology, such as artificial intelligence (AI), to augment care are supporting the market growth.

Intravenous Solutions Industry Segmentation:

Breakup by Type:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

Total parenteral nutrition dominates the market

Total parenteral nutrition (TPN) is dominating the market as it is used to fulfill all the nutritional requirements of patients who cannot eat or absorb enough food through regular digestive means. Additionally, it finds extensive applications across various medical fields, including oncology, gastroenterology, and intensive care units (ICUs). Furthermore, the rising number of chronic conditions, such as cancer and gastrointestinal diseases, that necessitate the use of TPN for nutritional support is propelling the market growth. Apart from this, increasing utilization of TPN to meet the nutritional needs of patients undergoing major surgical procedures is catalyzing the market growth. Moreover, the recent improvements in TPN formulation and administration technology, ensuring safer and more personalized nutrition support, are strengthening the market growth.

Breakup by Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

Carbohydrates serve as a primary energy source for the human body. They are essential in providing immediate energy, particularly for patients unable to consume food orally. In addition, they are used by all cells in the body, which makes them suitable for a diverse range of patients, irrespective of their specific conditions. Furthermore, carbohydrates can be easily administered through IV solutions, allowing for controlled delivery.

Minerals, such as magnesium, calcium, potassium, and sodium, play critical roles in maintaining various bodily functions, including muscle contraction, nerve transmission, and maintaining fluid balance. Furthermore, IV solutions with specific mineral compositions are essential in correcting electrolyte imbalance, restoring normal cellular function, and stabilizing the patient. Apart from this, minerals are utilized in various medical scenarios, from emergency care to post-operative recovery and chronic disease management.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

North America exhibits a clear dominance, accounting for the largest intravenous solutions market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America hosts one of the world's most advanced healthcare systems comprising state-of-the-art medical facilities equipped with cutting-edge technology that is fostering a conducive environment for the utilization of IV solutions. Additionally, the region's healthcare spending is among the highest globally, enabling greater access to quality medical care, including treatments requiring intravenous solutions. Furthermore, the implementation of a comprehensive regulatory framework by the regional governments to ensure that IV solutions meet strict quality and safety standards is boosting the market growth. Apart from this, the high prevalence of chronic conditions like diabetes, heart disease, and cancer, which necessitates regular medical interventions, is acting as another growth-inducing factor. Besides this, North America has a strong network of universities, research institutions, and pharmaceutical companies that are actively investing in developing new intravenous solutions and improving existing ones.

Competitive Landscape:

The major players are focusing on creating advanced intravenous products, such as the formulation of new solutions with improved efficiency, the integration of innovative technologies like smart infusion pumps, and the development of personalized therapies. In addition, they are expanding their reach into these regions by setting up new manufacturing facilities, partnering with local distributors, and adapting products to meet specific regional needs. Furthermore, leading companies are engaging in mergers and acquisitions to diversify their product portfolios, leverage synergies, and expand their geographical presence. Moreover, they are placing strong emphasis on quality control and regulatory compliance to ensure that their products meet all relevant safety and efficacy standards. Besides this, top companies in the IV solutions market are focusing on environmentally responsible manufacturing processes and materials by reducing waste and energy consumption and using sustainable resources.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Ajinomoto Co., Inc.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Grifols S.A.
  • Otsuka Pharmaceutical.

Key Questions Answered in This Report

  • 1.What are intravenous solutions?
  • 2.How big is the global intravenous solutions market?
  • 3.
  • What is the expected growth rate of the global intravenous solutions market during 2025-2033?
  • 4.What are the key factors driving the global intravenous solutions market?
  • 5.What is the leading segment of the global intravenous solutions market based on type?
  • 6.What is the leading segment of the global intravenous solutions market based on nutrients?
  • 7.What are the key regions in the global intravenous solutions market?
  • 8.Who are the key players/companies in the global intravenous solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Nutrients
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Partial Parenteral Nutrition
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Total Parenteral Nutrition
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Nutrients

  • 7.1 Carbohydrates
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Salts and Electrolytes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Minerals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitamins
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Amino Acids
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intravenous Solutions Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Ajinomoto
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 B. Braun Melsungen
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 Baxter International Inc.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Grifols
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Otsuka Pharmaceutical
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Solutions Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Intravenous Solutions Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Intravenous Solutions Market: Breakup by Nutrients (in %), 2024
  • Figure 5: Global: Intravenous Solutions Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Intravenous Solutions Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Intravenous Solutions Industry: SWOT Analysis
  • Figure 8: Global: Intravenous Solutions Industry: Value Chain Analysis
  • Figure 9: Global: Intravenous Solutions Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Intravenous Solutions (Minerals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Intravenous Solutions (Vitamins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Intravenous Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Europe: Intravenous Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Europe: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Asia Pacific: Intravenous Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Asia Pacific: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Middle East and Africa: Intravenous Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Middle East and Africa: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Latin America: Intravenous Solutions Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Latin America: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Intravenous Solutions Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intravenous Solutions Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Intravenous Solutions Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million USD), 2025-2033
  • Table 4: Global: Intravenous Solutions Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Intravenous Solutions: Raw Material Requirements
  • Table 6: Global: Intravenous Solutions Market: Competitive Structure
  • Table 7: Global: Intravenous Solutions Market: Key Players